Evidence map›Paper›PMID 27993549›Full record

ArticleThe Journal of investigative dermatology2017

Higher Nevus Count Exhibits a Distinct DNA Methylation Signature in Healthy Human Skin: Implications for Melanoma.

Leonie Roos, Johanna K Sandling, Christopher G Bell, Daniel Glass, Massimo Mangino, Tim D Spector, Panos Deloukas, Veronique Bataille, Jordana T Bell

Open access · hybridAbstract readComparative Study
In one paragraph

Article in The Journal of investigative dermatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Non-coding 886 (Epigenetics · 2024
    Review
  5. Article
  6. Genetic effects on the skin methylome in healthy older twins.American journal of human genetics · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Melanoma susceptibility: an update on genetic and epigenetic findings.International journal of molecular epidemiology and genetics · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Leonie RoosDepartment of Twin Research and Genetic Epidemiology, King's College London, London, UK; MRC London Institute of Medical Sciences, London, UK; Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK. Electronic address: l.roos@imperial.ac.uk.
Johanna K SandlingDepartment of Medical Sciences, Molecular Medicine and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Christopher G BellDepartment of Twin Research and Genetic Epidemiology, King's College London, London, UK; MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK; Human Development and Health Academic Unit, Institute of Developmental Sciences, University of Southampton, Southampton, UK; Epigenomic Medicine, Centre for Biological Sciences, Faculty of Environmental and Natural Sciences, University of Southampton, Southampton, UK.
Daniel GlassDepartment of Twin Research and Genetic Epidemiology, King's College London, London, UK.
Massimo ManginoDepartment of Twin Research and Genetic Epidemiology, King's College London, London, UK.
Tim D SpectorDepartment of Twin Research and Genetic Epidemiology, King's College London, London, UK.
Panos DeloukasWilliam Harvey Research Institute, Queen Mary University of London, London, UK.
Veronique BatailleDepartment of Twin Research and Genetic Epidemiology, King's College London, London, UK.
Jordana T BellDepartment of Twin Research and Genetic Epidemiology, King's College London, London, UK.
King's College London · GBQueen Mary University of London · GBUppsala University · SE

Funding

Medical Research Council G0900339Wellcome Trust
6 · The paper itself

Abstract

High nevus count is the strongest risk factor for melanoma, and although gene variants have been discovered for both traits, epigenetic variation is unexplored. We investigated 322 healthy human skin DNA methylomes associated with total body nevi count, incorporating genetic and transcriptomic variation. DNA methylation changes were identified at genes involved in melanocyte biology, such as RAF1 (P = 1.2 × 10

Indexed as

AdultCase-Control StudiesDNA MethylationEpigenomicsFemaleGene Expression Regulation, NeoplasticGenetic Predisposition to DiseaseGenome-Wide Association StudyGenotypeHumansMaleMelanomaNevusPhenotypeReference ValuesRegistries

Identifiers

PMID27993549
PMCPMC5754330
OpenAlexW2562188554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.